04:28 PM EDT, 10/16/2025 (MT Newswires) -- Coleen Glessner, Executive Vice President, Quality, Ethics, and Compliance, on October 07, 2025, sold 30,608 shares in Emergent Biosolutions ( EBS ) for $306,080. Following the Form 4 filing with the SEC, Glessner has control over a total of 144,319 common shares of the company, with 144,319 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1367644/000191917025000004/xslF345X05/wk-form4_1760646078.xml